Bio-Rad s Chairman Not Mad About Beef, Or Wall Street | GenomeWeb

ORLANDO, Fla. — Bio-Rad Chairman David Schwartz will tell you that he is not involved in the day-to-day running of the Hercules, Calif.-based molecular biology tools company, but the 80-year-old co-founder of the company does have a stake in the firm.

On Tuesday, Schwartz, who stepped down as Bio-Rad's CEO in 2002, spoke at a company media event at Pittcon 2005, held here through Friday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.